Font Size:
a
A
A
Keyword [multi-targeted]
Result: 21 - 21 | Page: 2 of 2
21.
The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
<<First
<Prev
Next>
Last>>
Jump to
